BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30711662)

  • 1. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colloids or powders: Which nanoparticle formulations do cells like more?
    Uskoković V; Huynh E; Tang S; Jovanović S; Wu VM
    Colloids Surf B Biointerfaces; 2019 Sep; 181():39-47. PubMed ID: 31121380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earthicle: The Design of a Conceptually New Type of Particle.
    Uskoković V; Pernal S; Wu VM
    ACS Appl Mater Interfaces; 2017 Jan; 9(2):1305-1321. PubMed ID: 28009506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
    Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
    Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
    Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
    J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
    Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
    Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
    Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic calcium phosphates nanocomposites for the intracellular hyperthermia of cancers of bone and brain.
    Adamiano A; Wu VM; Carella F; Lamura G; Canepa F; Tampieri A; Iafisco M; Uskoković V
    Nanomedicine (Lond); 2019 May; 14(10):1267-1289. PubMed ID: 31124760
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
    Pernal S; Wu VM; Uskoković V
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma.
    Huang WC; Lu IL; Chiang WH; Lin YW; Tsai YC; Chen HH; Chang CW; Chiang CS; Chiu HC
    J Control Release; 2017 May; 254():119-130. PubMed ID: 28336375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
    Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
    Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of magnetic hyperthermia performance and biocompatibility of magnetite and novel Fe-doped hardystonite nanoparticles for potential bone cancer therapy.
    Farzin A; Hassan S; Emadi R; Etesami SA; Ai J
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():930-938. PubMed ID: 30813100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
    Zaloga J; Janko C; Nowak J; Matuszak J; Knaup S; Eberbeck D; Tietze R; Unterweger H; Friedrich RP; Duerr S; Heimke-Brinck R; Baum E; Cicha I; Dörje F; Odenbach S; Lyer S; Lee G; Alexiou C
    Int J Nanomedicine; 2014; 9():4847-66. PubMed ID: 25364244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of thiol-functionalized superparamagnetic iron oxide nanoparticles.
    Britos TN; Castro CE; Bertassoli BM; Petri G; Fonseca FLA; Ferreira FF; Haddad PS
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():171-179. PubMed ID: 30889689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity.
    Paolini A; Guarch CP; Ramos-López D; de Lapuente J; Lascialfari A; Guari Y; Larionova J; Long J; Nano R
    J Appl Toxicol; 2016 Apr; 36(4):510-20. PubMed ID: 26708321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.